194 related articles for article (PubMed ID: 35534310)
1. Association of Anti-Rotavirus IgA Seroconversion with Growth, Environmental Enteric Dysfunction and Enteropathogens in Rural Pakistani Infants.
Ahmed S; Iqbal J; Sadiq K; Umrani F; Rizvi A; Kabir F; Jamil Z; Syed S; Ehsan L; Zulqarnain F; Sajid M; Hotwani A; Rahman N; Ma JZ; McNeal M; Ann Costa Clemens S; Talat Iqbal N; Moore SR; Ali A
Vaccine; 2022 May; 40(25):3444-3451. PubMed ID: 35534310
[TBL] [Abstract][Full Text] [Related]
2. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
[TBL] [Abstract][Full Text] [Related]
3. Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.
Lee B; Carmolli M; Dickson DM; Colgate ER; Diehl SA; Uddin MI; Islam S; Hossain M; Rafique TA; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; McNeal MM; Petri WA; Qadri F; Haque R; Kirkpatrick BD
Clin Infect Dis; 2018 Jul; 67(2):186-192. PubMed ID: 29394355
[TBL] [Abstract][Full Text] [Related]
4. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
Baker JM; Tate JE; Leon J; Haber MJ; Lopman BA
PLoS Med; 2019 Dec; 16(12):e1003005. PubMed ID: 31887139
[TBL] [Abstract][Full Text] [Related]
5. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
[TBL] [Abstract][Full Text] [Related]
6. Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.
Velasquez-Portocarrero DE; Wang X; Cortese MM; Snider CJ; Anand A; Costantini VP; Yunus M; Aziz AB; Haque W; Parashar U; Sisay Z; Soeters HM; Hyde TB; Jiang B; Zaman K
Lancet Infect Dis; 2022 Nov; 22(11):1606-1616. PubMed ID: 35961362
[TBL] [Abstract][Full Text] [Related]
7. TLR genetic variation is associated with Rotavirus-specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine.
Miya TV; Groome MJ; de Assis Rosa D
Vaccine; 2021 Nov; 39(48):7028-7035. PubMed ID: 34740476
[TBL] [Abstract][Full Text] [Related]
8. Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach.
Mwila-Kazimbaya K; Bosomprah S; Chilyabanyama ON; Chisenga CC; Chibuye M; Laban NM; Simuyandi M; Huffer B; Iturriza-Gomara M; Choy RKM; Chilengi R
PLoS One; 2023; 18(11):e0293101. PubMed ID: 37976323
[TBL] [Abstract][Full Text] [Related]
9. Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants.
Church JA; Chasekwa B; Rukobo S; Govha M; Lee B; Carmolli MP; Ntozini R; Mutasa K; McNeal MM; Majo FD; Tavengwa NV; Kirkpatrick BD; Moulton LH; Humphrey JH; Prendergast AJ
Vaccine; 2020 Mar; 38(13):2870-2878. PubMed ID: 32088018
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction.
Mwape I; Bosomprah S; Mwaba J; Mwila-Kazimbaya K; Laban NM; Chisenga CC; Sijumbila G; Simuyandi M; Chilengi R
PLoS One; 2017; 12(12):e0187761. PubMed ID: 29281659
[TBL] [Abstract][Full Text] [Related]
11. Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.
Witte D; Handley A; Jere KC; Bogandovic-Sakran N; Mpakiza A; Turner A; Pavlic D; Boniface K; Mandolo J; Ong DS; Bonnici R; Justice F; Bar-Zeev N; Iturriza-Gomara M; Ackland J; Donato CM; Cowley D; Barnes G; Cunliffe NA; Bines JE
Lancet Infect Dis; 2022 May; 22(5):668-678. PubMed ID: 35065683
[TBL] [Abstract][Full Text] [Related]
12. A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants.
Cohet C; Cheuvart B; Moerman L; Bi D; Caplanusi A; Kariyappa M; Lalwani S; Mitra M; Sapru A; Saha S; Varughese PV; Kompithra RZ; Gandhi S
Hum Vaccin Immunother; 2021 Nov; 17(11):4646-4653. PubMed ID: 34428112
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Fecal Biomarkers of Environmental Enteropathy and Rotavirus Vaccine Response in Nicaraguan Infants.
Becker-Dreps S; Vilchez S; Bucardo F; Twitchell E; Choi WS; Hudgens MG; Perez J; Yuan L
Pediatr Infect Dis J; 2017 Apr; 36(4):412-416. PubMed ID: 27977553
[TBL] [Abstract][Full Text] [Related]
14. The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
Lee B; Dickson DM; Alam M; Afreen S; Kader A; Afrin F; Ferdousi T; Damon CF; Gullickson SK; McNeal MM; Bak DM; Tolba M; Carmolli MP; Taniuchi M; Haque R; Kirkpatrick BD
Vaccine; 2020 Jan; 38(1):90-99. PubMed ID: 31607603
[TBL] [Abstract][Full Text] [Related]
15. Association of human leukocyte antigen alleles and supertypes with immunogenicity of oral rotavirus vaccine given to infants in China.
Liu Y; Guo T; Yu Q; Zhang H; Du J; Zhang Y; Xia S; Yang H; Li Q
Medicine (Baltimore); 2018 Oct; 97(40):e12706. PubMed ID: 30290669
[TBL] [Abstract][Full Text] [Related]
16. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
Rongsen-Chandola T; Strand TA; Goyal N; Flem E; Rathore SS; Arya A; Winje BA; Lazarus R; Shanmugasundaram E; Babji S; Sommerfelt H; Vainio K; Kang G; Bhandari N
Vaccine; 2014 Aug; 32 Suppl 1():A134-9. PubMed ID: 25091668
[TBL] [Abstract][Full Text] [Related]
17. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
[TBL] [Abstract][Full Text] [Related]
18. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial.
Ali A; Kazi AM; Cortese MM; Fleming JA; Moon S; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi AK
PLoS One; 2015; 10(6):e0127622. PubMed ID: 26035743
[TBL] [Abstract][Full Text] [Related]
19. In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
Kazimbaya KM; Chisenga CC; Simuyandi M; Phiri CM; Laban NM; Bosomprah S; Permar SR; Munsaka S; Chilengi R
PLoS One; 2020; 15(11):e0240714. PubMed ID: 33170860
[TBL] [Abstract][Full Text] [Related]
20. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan.
Harris V; Ali A; Fuentes S; Korpela K; Kazi M; Tate J; Parashar U; Wiersinga WJ; Giaquinto C; de Weerth C; de Vos WM
Gut Microbes; 2018 Mar; 9(2):93-101. PubMed ID: 28891751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
